Granules India Limited is a leading contract manufacturer and international supplier of active pharmaceutical ingredients (APIs) and pharmaceutical formulation intermediates (PFIs), with a concentration on paracetamol, metformin and ibuprofen-based products. The company's advantage comes from its large scale, which can cater to the requirements of many clients; Granules's manufacturing facilities have been approved by the United States Food and Drug Administration and other foreign regulatory agencies. In 2007, IFC helped finance a $32 million expansion of the firm’s API, granulation, and formulation capacities.
IFC role and development impact:
- Financing and guidance on management and financial structure to position the company for future growth and to attract additional funding
- Increased the availability and affordability of medicine
